Stockreport

Allogene Therapeutics, Inc. (ALLO) CEO David Chang on Q1 2022 Results - Earnings Call Transcript [Seeking Alpha]

Allogene Therapeutics, Inc.  (ALLO) 
Last allogene therapeutics, inc. earnings: 2/27 04:30 am Check Earnings Report
PDF Allogene Therapeutics, Inc. (NASDAQ:ALLOCompany ParticipantsChristine Cassiano - Chief Communications OfficerDavid Chang - President and Chief Executive OfficerRafael Am [Read more]